News

New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...
Immunofoco, a company dedicated to advancing cell therapies for solid tumors, announced that its independently developed, innovative lentiviral vector-based In Vivo CAR-T Technology Platform made a ...
GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial.GEN-1013 was studied in aggressive murine cancer models ...
Met Gala 2025 red carpet saw a powerful lineup of South Asian representation. From reimagined heritage textiles and ...
Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...
Abstract: The zero-sequence current (ZSC ... This method significantly reduces the calculation time of the modulation and achieves the equivalent effect of the traditional space vector pulse width ...
Among those, the effect was greater: those with an artistic hobby in the 'beauty' group scored over 25% higher on average for ...
A new technical paper titled “Memory Prefetching Evaluation of Scientific Applications on A Modern HPC Arm-based Processor” ...
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell TherapyLONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc ...